BIOHAVEN PHARMACTL HLDG CO L's ticker is and the CUSIP is G11196955. A total of 3 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,048,000 | +418.7% | 212,000 | +400.0% | 0.04% | +414.3% |
| Q2 2022 | $6,178,000 | -35.2% | 42,400 | -47.3% | 0.01% | -22.2% |
| Q1 2022 | $9,533,000 | -36.9% | 80,400 | -26.6% | 0.01% | -40.0% |
| Q4 2021 | $15,103,000 | +8836.7% | 109,600 | +6347.1% | 0.02% | – |
| Q3 2021 | $169,000 | +2.4% | 1,700 | 0.0% | 0.00% | – |
| Q2 2021 | $165,000 | -43.7% | 1,700 | +3853.5% | 0.00% | -100.0% |
| Q1 2021 | $293,000 | -95.4% | 43 | -94.2% | 0.00% | -87.5% |
| Q4 2020 | $6,385,000 | +1016.3% | 745 | +746.6% | 0.01% | +700.0% |
| Q3 2020 | $572,000 | -14.9% | 88 | -4.3% | 0.00% | 0.0% |
| Q2 2020 | $672,000 | +100.0% | 92 | -7.1% | 0.00% | 0.0% |
| Q1 2020 | $336,000 | -79.6% | 99 | -67.2% | 0.00% | -75.0% |
| Q4 2019 | $1,644,000 | +220.5% | 302 | +145.5% | 0.00% | +300.0% |
| Q3 2019 | $513,000 | -80.2% | 123 | -79.2% | 0.00% | -85.7% |
| Q2 2019 | $2,592,000 | +1022.1% | 592 | +1215.6% | 0.01% | +600.0% |
| Q1 2019 | $231,000 | +20.3% | 45 | -13.5% | 0.00% | 0.0% |
| Q4 2018 | $192,000 | +2642.9% | 52 | +2500.0% | 0.00% | – |
| Q2 2018 | $7,000 | -88.1% | 2 | -99.5% | 0.00% | -100.0% |
| Q1 2018 | $59,000 | – | 428 | +42700.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 27,600 | $2,018,000 | 0.01% |
| SIMPLEX TRADING, LLC | 92 | $672,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |